Vestmark Advisory Solutions, Inc. Galapagos Nv Transaction History

Vestmark Advisory Solutions, Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Oct 19, 2020	SELL	$122.47 - $213.56 $363,123 - $633,205	-2,965 Closed	0 $0
Q2 2020 Aug 13, 2020	BUY	$185.52 - $231.25 $5,565 - $6,937	30 Added 1.02%	2,965 $585,000
Q1 2020 May 06, 2020	BUY	$143.0 - $274.03 $419,705 - $804,278	2,935 New	2,935 $575,000
Q4 2019 Feb 14, 2020	SELL	$146.12 - $215.82 $410,012 - $605,590	-2,806 Closed	0 $0
Q3 2019 Nov 05, 2019	BUY	$130.44 - $187.64 $83,351 - $119,901	639 Added 29.49%	2,806 $428,000

Q2 2019 Aug 20, 2019	BUY	$111.45 - $128.93 $3,009 - $3,481	27 Added 1.26%	2,167 $279,000
Q1 2019 May 14, 2019	BUY	$89.61 - $117.78 $191,765 - $252,049	2,140 New	2,140 $252,000

16.5M

77.1K

57.2K

Ticker GLPG
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 65,835,500
Market Cap $1.67B
Description
Galapagos NV, an integrated biopharmaceutical company, engages in the discovery, development, and commercialization of various medicines for high unmet medical need. Its pipeline products include filgotinib, a JAK1 inhibitor that is in various phases of clinical trials for the treatment of rheumatoid arthritis, Crohn's disease, ulcerative coliti...

Get notified when there are updates to the investment portfolio of Vestmark Advisory Solutions, Inc., based on Form 13F filings with the SEC.

Stay updated on Vestmark Advisory Solutions, Inc. with notifications on news.